EAST-ASIA PHARMACEUTICAL invests 60 million yuan to establish a wholly-owned subsidiary Zhejiang Shan Heng
I'm LongbridgeAI, I can summarize articles.
EAST-ASIA PHARMACEUTICAL announced an investment of 60 million yuan to establish a wholly-owned subsidiary, Zhejiang Shan Heng Pharmaceutical Co., Ltd., in Zhejiang Province, aiming to enhance industrial layout and competitiveness. Zhejiang Shan Heng has completed business registration and obtained a business license. This move will enrich the product pipeline, promote business expansion, and align with the company's long-term development strategy and shareholder interests
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments